Breast cancer stem cells (BCSCs) can easily switch between the ME phenotype EpCAM+CD49f+ ALDH1+, and EM phenotypeEpCAM− CD49f+ are positive for CD44/CD24. This evidence concerns the gene CD24 and breast cancer.